What are you looking for?

Newsroom

News from the Centre

Dr. Lina Herhaus heads the junior research group “Immune Signalling” at the HZI.
Scientist Dr. Lina Herhaus, who heads the junior research group “Immune Signaling” at the Helmholtz Centre for Infection Research (HZI), will receive one of the coveted Exploration Grants from the Boehringer Ingelheim Stiftung starting in March 2026. This program offers outstanding basic researchers in biology, chemistry and medicine the opportunity to explore new directions in research. In addition, Herhaus received the Walther Flemming Award from the German Society of Cell Biology (DGZ) and ibidi GmbH on October 27, 2025. The prize is endowed with 3,000 euros and is awarded to experienced postdoctoral researchers and young scientists for outstanding achievements in cell biology.
29.10.2025
Portrait Caroline Klett-Tammen
Poliomyelitis, also known as polio, is a contagious disease caused by the poliovirus. Thanks to the development of effective vaccines, the poliovirus has been largely eradicated and was endemic in only two countries in 2024. However, until the virus is eradicated worldwide, vaccination protection is important in Germany as well, as the virus could be reintroduced at any time. Epidemiologists at the Helmholtz Centre for Infection Research (HZI) have now shown that many people do not know their vaccination status and cannot find it on their vaccination record. In an interview on the occasion of World Polio Day on October 24, Dr. Carolina Klett-Tammen, deputy head of Clinical Epidemiology in the department “Epidemiology” at the HZI, explains the study results, which have been published in the journal BMC Public Health.
23.10.2025
Light microscopy of red blood cells, some are infected with Plasmodium
It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common medications are also becoming less effective against malaria, a tropical disease caused by a parasite. To counteract this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has now developed a new drug candidate that can kill the malaria pathogen even when existing drugs are no longer effective. The team has now published its findings in the journal Angewandte Chemie.
22.10.2025
Facts & Figures
Employees
0 +
Employees
Basic funding in 2024 (plus third-party funding)
0 Mio.
Basic funding in 2024 (plus third-party funding)
Publications in 2024
0
Publications in 2024
One center - six locations

The HZI locations at a glance

The Sites of the Helmholtz Centre for Infection Research are distributed all over Germany. In addition to the main campus in Braunschweig, there are facilities in five other cities: Hamburg, Hanover, Saarbrücken, Würzburg and Greifswald.

Please note: Once you watch the map, data will be transmitted to Openstreetmap. For more information, see Openstreetmap Privacy.

One center - six locations

The HZI locations at a glance

The Sites of the Helmholtz Centre for Infection Research are distributed all over Germany. In addition to the main campus in Braunschweig, there are facilities in five other cities: Hamburg, Hanover, Saarbrücken, Würzburg and Greifswald.

Saarbrücken
Würzburg
Greifswald
Hamburg

Events

Scientific
18
November
2025
10.00 am | Braunschweig
Scientific
18
November
2025
4.00 pm | Braunschweig
Scientific
24
November
2025
1.00 pm | Hannover
Conference
Host: TWINCORE
Public
01
December
2025
9.00 am | Braunschweig
Show all events

Publication database

Publication overview

The publication database contains over 10,000 publications by HZI employees.

To publication database